14 January 2025 : Original article
Living Donor Liver Transplantation with Small Left Lobe Grafts: Prospective Validation of Utility of Splenectomy in Selected Recipients
Hajime Matsushima1ABCDEF*, Akihiko Soyama
1BCD, Takanobu Hara 1BCD, Takashi Hamada 1BCD, Yuta Kawaguchi1BCD, Kazushige Migita1BCD, Ayaka Satoh1BCD, Yamashita Mampei 1BCD, Hajime Imamura 1BCD, Ayaka Kinoshita1BCD, Tomohiko Adachi1BCD, Susumu Eguchi1BCD
DOI: 10.12659/AOT.946374
Ann Transplant 2025; 30:e946374
Table 4 Summary of patients who received living donor liver transplantation with left lobe grafts in era 3.
| Case | Year | Recipient age | Donor age | Diagnosis | MELD | GRWR, % | GW/SLV, % | Splenoctomy | Indication for splenoctomy | Outcomes |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2021 | 64 | 59 | NASH | 11 | 0.722 | 36.9 | Yes | PVP >20 cmHO | Alive |
| 2 | 2021 | 61 | 30 | HBV | 24 | 1.105 | 42.4 | No | – | Alive |
| 3 | 2021 | 37 | 48 | Budd-Chiari | 18 | 0.534 | 30.1 | No | – | Alive |
| 4 | 2021 | 51 | 54 | PBC | 12 | 0.542 | 27.3 | Yes | PVP >20 cmHO | Alive |
| 5 | 2021 | 66 | 60 | NASH | 13 | 0.583 | 34.4 | Yes | PVP >20 cmHO | Alive |
| 6 | 2022 | 42 | 40 | Cryptogenic | 12 | 0.65 | 31.1 | Yes | Thrombocytopenia | Alive |
| 7 | 2022 | 47 | 50 | Alcoholic | 13 | 0.755 | 31.1 | Yes | PVP >20 cmHO | Alive |
| 8 | 2022 | 54 | 23 | NASH | 18 | 0.465 | 28.5 | Yes | Thrombocytopenia | Alive |
| 9 | 2023 | 64 | 33 | Alcoholic | 12 | 0.651 | 33.2 | No | – | Alive |
| 10 | 2023 | 68 | 37 | Alcoholic | 35 | 0.713 | 38.4 | Yes | Thrombocytopenia | EAD, SFSS, alive |
| 11 | 2023 | 65 | 34 | NASH | 24 | 0.546 | 29.2 | No | – | Alive |
| 12 | 2023 | 38 | 32 | Alcoholic | 26 | 0.525 | 30.1 | No (SAL) | Thrombocytopenia | EAD, SFSS, alive |
| 13 | 2023 | 52 | 50 | Alcoholic | 17 | 0.783 | 40.6 | Yes | Thrombocytopenia | Alive |
| 14 | 2023 | 52 | 50 | PSC | 13 | 1.097 | 48.0 | No | – | SFSS, alive |
| 15 | 2024 | 49 | 47 | Alcoholic | 22 | 0.582 | 30.9 | Yes | Thrombocytopenia | Alive |